Note on Valuing a Biotech Company Note on Valuing a Biotech Company

Note on Valuing a Biotech Company

9B08N005

James E. Hatch
    • $3.99
    • $3.99

Publisher Description

This technical note discusses the methods and factors that investment bankers and venture capitalists take into account when placing a value on the shares of biotech companies.

GENRE
Business & Personal Finance
RELEASED
2008
March 11
LANGUAGE
EN
English
LENGTH
12
Pages
PUBLISHER
Richard Ivey School of Business Foundation
SELLER
Ivey Business School Foundation
SIZE
408.1
KB

More Books Like This

Note on Valuation for Venture Capital Note on Valuation for Venture Capital
Note on Valuation for Venture Capital
2009
Creating Shareholder Value Creating Shareholder Value
Creating Shareholder Value
1999
Security Analysis and Business Valuation on Wall Street Security Analysis and Business Valuation on Wall Street
Security Analysis and Business Valuation on Wall Street
2010
Value Value
Value
2010
Raising Venture Capital for the Serious Entrepreneur Raising Venture Capital for the Serious Entrepreneur
Raising Venture Capital for the Serious Entrepreneur
2007
The Corporate Life Cycle The Corporate Life Cycle
The Corporate Life Cycle
2024

More Books by James E. Hatch

Note on Private Company Valuation Note on Private Company Valuation
Note on Private Company Valuation
2001
Lululemon Athletica: Pitching an IPO Lululemon Athletica: Pitching an IPO
Lululemon Athletica: Pitching an IPO
2011
Note on Venture Capital Note on Venture Capital
Note on Venture Capital
2004
Licensing of ApoEp1.B Peptide Technology Licensing of ApoEp1.B Peptide Technology
Licensing of ApoEp1.B Peptide Technology
2005
Legal Aspects of Mergers & Acquisitions in Canada Legal Aspects of Mergers & Acquisitions in Canada
Legal Aspects of Mergers & Acquisitions in Canada
2010
Note on Contents of a Term Sheet Note on Contents of a Term Sheet
Note on Contents of a Term Sheet
2002